File Download
 
 
Supplementary

Conference Paper: Identifying therapeutic chemical agents for osteoarthritis by high throughput screening
  • Basic View
  • Metadata View
  • XML View
TitleIdentifying therapeutic chemical agents for osteoarthritis by high throughput screening
 
AuthorsTsui, YK
Leung, VY
Kao, RY
Masuda, K
Chan, D
Cheung, KM
 
Issue Date2009
 
CitationThe 55th Annual Meeting of the Orthopaedic Research Society, Las Vegas, NV., 22-25 February 2009. [How to Cite?]
 
AbstractINTRODUCTION: An articular cartilage lesion, notably generated by osteoarthritis (OA), is initiated partly by the loss of proteoglycan content from the extracellular matrix and manifests as pain or disturbed joint function [1]. Strategies that restore the proteoglycan content would be of therapeutic benefit to prevent, delay, or even reverse the progression of the lesion. Numerous clinical and experimental approaches have been widely applied [2-4] to relieve the pain or induce healing of the lesion; however these require surgical intervention. Orally administrated …
 
DescriptionPoster no. 1138
 
DC FieldValue
dc.contributor.authorTsui, YK
 
dc.contributor.authorLeung, VY
 
dc.contributor.authorKao, RY
 
dc.contributor.authorMasuda, K
 
dc.contributor.authorChan, D
 
dc.contributor.authorCheung, KM
 
dc.date.accessioned2010-07-13T03:42:18Z
 
dc.date.available2010-07-13T03:42:18Z
 
dc.date.issued2009
 
dc.description.abstractINTRODUCTION: An articular cartilage lesion, notably generated by osteoarthritis (OA), is initiated partly by the loss of proteoglycan content from the extracellular matrix and manifests as pain or disturbed joint function [1]. Strategies that restore the proteoglycan content would be of therapeutic benefit to prevent, delay, or even reverse the progression of the lesion. Numerous clinical and experimental approaches have been widely applied [2-4] to relieve the pain or induce healing of the lesion; however these require surgical intervention. Orally administrated …
 
dc.description.naturepostprint
 
dc.descriptionPoster no. 1138
 
dc.identifier.citationThe 55th Annual Meeting of the Orthopaedic Research Society, Las Vegas, NV., 22-25 February 2009. [How to Cite?]
 
dc.identifier.hkuros165908
 
dc.identifier.urihttp://hdl.handle.net/10722/61554
 
dc.languageeng
 
dc.relation.ispartof55th ORS Annual Meeting 2009
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.titleIdentifying therapeutic chemical agents for osteoarthritis by high throughput screening
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Tsui, YK</contributor.author>
<contributor.author>Leung, VY</contributor.author>
<contributor.author>Kao, RY</contributor.author>
<contributor.author>Masuda, K</contributor.author>
<contributor.author>Chan, D</contributor.author>
<contributor.author>Cheung, KM</contributor.author>
<date.accessioned>2010-07-13T03:42:18Z</date.accessioned>
<date.available>2010-07-13T03:42:18Z</date.available>
<date.issued>2009</date.issued>
<identifier.citation>The 55th Annual Meeting of the Orthopaedic Research Society, Las Vegas, NV., 22-25 February 2009.</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/61554</identifier.uri>
<description>Poster no. 1138</description>
<description.abstract>INTRODUCTION: An articular cartilage lesion, notably generated by osteoarthritis (OA), is initiated partly by the loss of proteoglycan content from the extracellular matrix and manifests as pain or disturbed joint function [1]. Strategies that restore the proteoglycan content would be of therapeutic benefit to prevent, delay, or even reverse the progression of the lesion. Numerous clinical and experimental approaches have been widely applied [2-4] to relieve the pain or induce healing of the lesion; however these require surgical intervention. Orally administrated &#8230;</description.abstract>
<language>eng</language>
<relation.ispartof>55th ORS Annual Meeting 2009</relation.ispartof>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<title>Identifying therapeutic chemical agents for osteoarthritis by high throughput screening</title>
<type>Conference_Paper</type>
<description.nature>postprint</description.nature>
<identifier.hkuros>165908</identifier.hkuros>
<bitstream.url>http://hub.hku.hk/bitstream/10722/61554/1/Abstract.pdf</bitstream.url>
</item>